Search Results
Jan 06, 2026, 11:19 ET MG Properties Acquires Sola Galleria Apartments in Farmers Branch, Texas
https://mgproperties.com ABOUT MG PROPERTIESMG Properties is a privately owned, fully integrated real estate company specializing in the investment, redevelopment, and management of multi-family assets. Headquartered in San Diego, California, MG Properties was founded in 1992 by Mark Gleiberman
More news about: MG Properties
Jan 06, 2026, 09:26 ET Gilgamesh Pharma Announces Positive Topline Phase 2a Results for Blixeprodil (GM-1020) in Major Depressive Disorder
was a randomized, double-blind, placebo-controlled, single-dose, cross-over study of blixeprodil 140 mg. Part B was a blinded, randomized, multiple-dose extension period of blixeprodil 140 vs. 210 mg, twice per week for 2 weeks. After conclusion of dosing in Part B, all subjects were followed for an additional
More news about: Gilgamesh Pharma
Jan 06, 2026, 09:06 ET SKIN ON FIRE? KIEHL'S ULTRA FACIAL CREAM MEDICATED TO THE RESCUE
itching due to eczema and rashesSpherical Rolling Emollients: Provides low-friction texture50mg α-Bisabolol: Helps to calm and soothe the skin250mg Dexpanthenol: Helps support skin barrier regeneration and repairUltra Facial Cream Medicated soothes
More news about: Kiehl's Since 1851
Jan 06, 2026, 09:00 ET GORGIE Rewrites the Wellness Playbook with the Launch of its First-Ever Protein Energy Drink
morning pick-me-ups, GORGIE Protein Energy drinks are gluten-free, keto-friendly and free of artificial sweeteners. Each can delivers 8g of protein, 150mg of green tea caffeine, plus functional wellness and beauty benefits from the additions of Biotin, B Vitamins and L-Theanine offering a functional and
More news about: GORGIE
Jan 06, 2026, 09:00 ET Magnesium Meets Innovation: Solaray Debuts Personalized Combos for Sleep, Stress and Peak Performance
Magnesium Glycinate Extra Strength: The beloved Mag Gly powder formula, now with even stronger potency. At 500 mg per serving, the easy-to-mix, unflavored powder offers the ultimate everyday support for muscles, bones, and relaxation.*Solaray's Magnesium
More news about: Solaray
Jan 06, 2026, 08:00 ET Zpeer Launches A-DHA-PT™, a High-Concentration DHA Supplement for Dogs, and Announces Research Collaboration with the University of Tokyo
clinical interest in nutritional approaches to neurological conditions in companion animals. Each compact 13 mm capsule delivers a high dose of over 150 mg of DHA, enabling efficient administration while minimizing pill burden for dogs. The product is available in bags containing 120 capsules.The
More news about: Zpeer Inc.
Jan 06, 2026, 06:22 ET BLA for subcutaneous formulation of Leqembi® accepted in China
If approved, the SC-AI of 500 mg could be used to administer a once-weekly dose at home from the initiation of treatment, as an alternative to the current IV administration every two weeks dose in the hospital setting. The injection time for each autoinjector (250mg injection) is approximately 15 seconds.
More news about: BioArctic
Jan 05, 2026, 09:20 ET Upstate Elevator Launches Its First-Ever THC Spirit Ahead of Dry January
Each 750 mL bottle packs 166 mg of THC, providing 10 mg per 1.5 oz serving, along with 38 mg of L-theanine to create relaxed, easygoing vibes. Smoky oak, bright citrus, and a playful flicker of jalapeño heat collide
More news about: Upstate Elevator
Jan 05, 2026, 09:00 ET American Life Expands Product Offerings into Washington and Alaska
in all states.MaxGrowth FIA is issued by American Life & Security Corp., 2900 S. 70th St., STE 400, Lincoln, NE 68506 (FIA5 11/2023; FIALR-MG 01/24, ICC24-FIANHR 001 01/24, FIAPB 001/24) or state variations. Product Features, limitations and availability vary; see the MaxGrowth FIA Disclosure
More news about: American Life
Jan 05, 2026, 08:30 ET MetaVia Reports Positive Statistically Significant Results from Its Phase 1b Clinical Trial of DA-1726 In Metabolic Disease - Demonstrating Strong Glycemic Response, Significant Direct Hepatic Effects, Robust Weight Loss and Favorable Safety Profile
statistically significant 9.8 cm (3.8 inch) (p=0.022) reduction in waist circumference. Patients also demonstrated a 12.3 mg/dL improvement in fasted glucose from a baseline of 105.3 mg/dL by Day 54. In addition, vibration-controlled transient elastography (VCTE) indicated a 23.7% reduction in liver stiffness
More news about: MetaVia Inc.
Jan 05, 2026, 08:05 ET Accord BioPharma's HERCESSI™ (trastuzumab-strf) Gains Preferred Status on Express Scripts National Commercial Formularies
metastatic disease.HERCESSITM (trastuzumab-strf) for injection is available as a single-dose vial for the 150 mg/vial strength and as a multiple-dose vial for the 420 mg/vial strength.Click here for
More news about: Accord BioPharma
Jan 05, 2026, 08:01 ET MONSTER ENERGY INTRODUCES MONSTER ENERGY STRAWBERRY SHOT
to experience it at the highly charged season opener, featuring dedicated sampling zones, athlete integrations and a FanFest takeover.With 160mg of caffeine, the classic Monster Energy blend and a legendary flavor profile built on the brand's heritage, Monster Energy Strawberry Shot is available
More news about: Monster Energy
Jan 05, 2026, 08:00 ET Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America
the Wegovy® savings offer.† Wegovy® pill is only approved in the US and will be available in 1.5 mg (starter dose), 4 mg, 9 mg, and 25 mg.3 For updates and information about the Wegovy® pill, please visit
More news about: NOVO NORDISK INC.
Jan 05, 2026, 08:00 ET DermTech 2.0 Expands DermTech Stratum™, a Non-Invasive Skin Genomics Service Offering
Smart Sticker® provides a 19mm collection area for lesional and non-lesional samples, collecting approximately 1.5mg of representative stratum corneum tissue, eliminating the need for often hard to obtain surgical biopsies in clinical research studies. Once collected,
More news about: DermTech LLC
Jan 05, 2026, 07:07 ET LEVEL UP YOUR FITNESS ROUTINE WITH RED BULL ZERO MISSED WORKOUTS
in 178 countries worldwide, and more than 12.6 billion cans of Red Bull were sold in 2024 alone. An 8.4 fl oz can of Red Bull Energy Drink contains 80 mg of caffeine, about the same as in a home-brewed cup of coffee. For more information, visit
More news about: Red Bull
Jan 05, 2026, 06:50 ET Protalix BioTherapeutics Letter to Stockholders
negative opinion issued in November 2025 by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) regarding the proposed 2 mg/kg every-four-weeks (E4W) dosing regimen for Elfabrio is underway, with an appeal outcome expected in the first quarter of 2026. This effort reflects Chiesi's
More news about: Protalix BioTherapeutics, Inc.
Jan 05, 2026, 05:00 ET CivicaScript announces availability of low-cost insulin and biosimilar for chronic inflammatory conditions in the US
in pre-filled syringes for subcutaneous injection in two strengths. The Wholesale Acquisition Cost for a 12-week supply of 90 mg is $985 and the WAC for a 12-week supply of 45 mg is $575. The biosimilar is available at this low, transparent price to CivicaScript's members and partners, including health
More news about: CivicaScript
Jan 04, 2026, 19:10 ET Ascletis Announces U.S. FDA IND Clearance for 13-Week Phase II Study of Its Oral Small Molecule GLP-1, ASC30, in Participants with Diabetes
Participants will be randomly assigned in a ratio of approximately 2:3:3:2 to 40 mg, 60 mg and 80 mg ASC30 tablets and matching placebo tablets, respectively. ASC30 will be titrated weekly from 1 mg to target doses of 40 mg, 60 mg and 80 mg. Enrollment is expected to begin in the first quarter of 2026. Ascletis
More news about: Ascletis Pharma Inc.
Jan 02, 2026, 13:29 ET Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize
89%), 55% in triglycerides (maximum 84%), and 49% in LDL cholesterol (maximum 87%). Among patients with elevated baseline triglycerides exceeding 150 mg/dL, mean reductions of 60% were observed at therapeutic doses."For the first time, we've shown that a single-course in vivo CRISPR treatment can
More news about: Equity Insider
Jan 01, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
in patients with chronic rhinosinusitis without nasal polyps (CRSsNP) did not meet its primary or secondary efficacy endpoints in either the 10 mg or 40 mg treatment arms." In light of the trial results, Insmed decided to discontinue development of brensocatib. On this news, Insmed's stock price
More news about: Pomerantz LLP
Jan 01, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rezolute, Inc. - RZLT
hypoglycemia events by self monitored blood glucose. There was an approximate 45% reduction in hypoglycemia events observed at the top ersodetug dose (10 mg/kg), which was not statistically significant compared to the placebo group, which experienced a 40% improvement. Furthermore, the study did not meet its
More news about: Pomerantz LLP
Jan 01, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
hypoglycemia events by self monitored blood glucose. There was an approximate 45% reduction in hypoglycemia events observed at the top ersodetug dose (10 mg/kg), which was not statistically significant compared to the placebo group, which experienced a 40% improvement. Furthermore, the study did not meet its
More news about: Pomerantz LLP
Dec 31, 2025, 08:07 ET The End of Shots? 5 Biotech Stocks Rethinking Diabetes
who are overweight with weight-related comorbidities, exceeding the target enrollment. The trial is evaluating weekly VK2735 doses of 7.5 mg, 12.5 mg, and 17.5 mg compared to placebo, with a primary endpoint of percent change in body weight from baseline at 78 weeks."We are excited to announce
More news about: USA News Group
Dec 30, 2025, 18:13 ET Vanda Pharmaceuticals Announces FDA Approval of NEREUS™ (tradipitant) for the Prevention of Vomiting Induced by Motion: A Historic Scientific Milestone in the Prevention of Motion Sickness
placebo-controlled clinical trials, somnolence (6%, 12%) and fatigue (6%, 8%) were adverse reactions reported in subjects who took a single dose of 85 mg or 170 mg NEREUS™, respectively. NEREUS™ may impair the mental and/or physical abilities required for driving a motor vehicle or operating heavy machinery.
More news about: Vanda Pharmaceuticals Inc.
Dec 26, 2025, 15:46 ET IDSS 2025: 90% das melhores operadoras do Brasil são Unimed
(SP), Unimed Ribeirão Preto (SP), Unimed do Estado de Santa Catarina – Federação Estadual das Cooperativas Médicas (SC), Unimed Uberlândia (MG), Unimed Belo Horizonte (MG) e Unimed Porto Alegre (RS).Além das cooperativas médicas, a Seguros Unimed também se destacou no IDSS 2025, ao alcançar nota máxima
More news about: Unimed